KEMPHARM, INC Transition Agreements
2 Contracts & Agreements
- Transition Agreement, dated as of May 6, 2023, between Zevra Therapeutics, Inc. and Richard W. Pascoe (Filed With SEC on May 8, 2023)
- Transition Agreement, dated as of January 4, 2023, as amended, between KemPharm, Inc. and Travis C. Mickle, Ph.D (Filed With SEC on January 9, 2023)
